Sino Medical Sciences Technology Inc. (688108.SH) plans to sell up to 6.6667% of the equity in its subsidiary, Sino Shenchang.

Sino Medical Sciences Technology Inc. (688108.SH) announced that its controlling subsidiary, Sino Shenchang, plans to transfer a total of up to 6.6667% of its equity to external investors (including Daoyuan Capital Management (Beijing) Co., Ltd., Hainan Kanyun Energy Technology Co., Ltd., Kailian (Beijing) Investment Fund Management Co., Ltd., Quanzhou Nuoyuan Entrepreneurship Investment Partnership (Limited Partnership), Lv Pengzhao) at a price of 100 million yuan. The company will waive its priority rights to purchase the equity of Sino Shenchang. After the completion of the equity transfer, it will not cause any changes to the company's shareholding percentage in Sino Shenchang.